Moreover, PRODH significantly impacts cancer progression through its dual role in ATP production and ROS generation, acting as both a tumor suppressor and oncogene, making it a critical therapeutic target for HCC [75, 76]. The gene discussed is PRODH; the disease is neoplasm.